Intersect Ent Inc
NASDAQ:XENT
Intersect Ent Inc
Other Equity
Intersect Ent Inc
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Intersect Ent Inc
NASDAQ:XENT
|
Other Equity
-$50k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Equity
-$1.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-13%
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Equity
$133m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
Stryker Corp
NYSE:SYK
|
Other Equity
-$377m
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Other Equity
-$8.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-15%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Equity
-$30.3m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
See Also
What is Intersect Ent Inc's Other Equity?
Other Equity
-50k
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Other Equity amounts to -50k USD.